Skip to main content

Advertisement

Fig. 20 | BMC Cancer

Fig. 20

From: Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations

Fig. 20

Sequence alignment of the protein targets representing angiogenesis (4AG8) and progression (1URW). The sequence identity and the sequence similarity were found to be 20.1 and 38.1, respectively. The active site shows higher degree of identity as demonstrated by the residues highlighted in yellow. The orange amino acids refer to the key inhibitory residues found to be complementary with each other

Back to article page